Microneedle-Mediated, Targeted Fungal Infection Therapy to Preserve Mobility in Diabetic Patients

ArrayPatch is pioneering a novel therapeutic platform using DerMap™ dissolving microneedles to deliver antifungal treatment directly into the nail bed and surrounding skin, targeting the $6 billion global onychomycosis (nail fungal infection) market. We focus especially on diabetic older adults, who are at highest risk for complications such as ulceration, mobility loss, and systemic infection. By bypassing the gastrointestinal tract and providing localized high-concentration delivery, our approach reduces systemic exposure and enhances treatment safety and adherence.